NFKB1 and urogenital neoplasm: Except for the expression of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)1, SS-31 treatment did not reduce the expression of inflammatory genes in the AA model, possibly because of the severity of induced kidney lesions as seen in the histological slides (Figure 1).